ST2 as a Marker for Risk of Therapy-Resistant Graft-versus-Host Disease and Death

BACKGROUND: No plasma biomarkers are associated with the response of acute graft-versus-host disease (GVHD) to therapy after allogeneic hematopoietic stem-cell transplantation. METHODS: We compared 12 biomarkers in plasma obtained a median of 16 days after therapy initiation from 10 patients with a...

詳細記述

保存先:
書誌詳細
主要な著者: Vander Lugt, Mark T., Braun, Thomas M., Hanash, Samir, Ritz, Jerome, Ho, Vincent T., Antin, Joseph H., Zhang, Qing, Wong, Chee-Hong, Wang, Hong, Chin, Alice, Gomez, Aurélie, Harris, Andrew C., Levine, John E., Choi, Sung W., Couriel, Daniel, Reddy, Pavan, Ferrara, James L. M., Paczesny, Sophie
フォーマット: Artigo
言語:Inglês
出版事項: 2013
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3943357/
https://ncbi.nlm.nih.gov/pubmed/23924003
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1213299
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料